ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Bisphenol A promotes esophageal carcinogenesis by activating the MMP1-PCOLCE regulatory axis and remodeling the tumor immune microenvironment.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bisphenol A (BPA), a ubiquitous environmental endocrine-disrupting chemical extensively used in plastic products, has been increasingly recognized for its carcinogenic potential. However, the molecular mechanisms underlying BPA-associated esophageal carcinogenesis remain incompletely understood. In this study, we integrated transcriptomic differential expression profiling, weighted gene co-expression network analysis (WGCNA), and a comprehensive machine-learning framework incorporating 127 predictive models to systematically identify critical molecular targets involved in BPA-driven esophageal cancer initiation. Single-cell RNA sequencing datasets were further employed to characterize the cell-type-specific distribution of these candidate targets within the tumor microenvironment. Molecular docking and molecular dynamics simulations were conducted to evaluate the binding affinity and interaction stability between BPA and target proteins. SHAP-based interpretability analysis was applied to pinpoint the core regulatory target. Subsequently, scTenifoldKnk virtual gene knockout analysis was utilized to explore downstream signaling mediators. A total of twelve key targets were identified, predominantly enriched in immune and epithelial cell subpopulations at the single-cell level. Docking analyses demonstrated strong binding affinities between BPA and multiple target proteins. Notably, SHAP analysis highlighted MMP1 as the central target mediating BPA-induced esophageal tumorigenesis, which was further supported by molecular dynamics simulations indicating a highly stable interaction. scTenifoldKnk analysis revealed PCOLCE as a potential downstream effector of MMP1 signaling. Collectively, our findings elucidate a previously unrecognized mechanism by which BPA promotes esophageal carcinogenesis through activation of the MMP1-PCOLCE regulatory axis and remodeling of the tumor immune microenvironment. This study provides novel molecular insights and potential therapeutic targets for future toxicological and translational investigations.
Indexed as
Identifiers
42373973What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.